Alcoholic neuropathy is a dubious disease in the area of the nervous system, with clinical performance being complex and often involving multi-system congestion. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can help align teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many diseases of the nervous system that have previously been difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to the changes in the condition.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of alcoholic neurological diseases. The platform serves a team of experts at home and abroad in the field of the neural system of the Chinese International Medical Service System, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.